2.12
6.00%
0.12
Handel nachbörslich:
2.10
-0.02
-0.94%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ESPR?
Forum
Prognose
Aktiensplit
Finanzdaten der Esperion Therapeutics Inc-Aktie (ESPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
327.09%
137.74
|
32.25 | 33.97 | 25.79 | 24.33 |
Cost Of Revenue |
53.47
|
- | - | - | - |
Gross Profit |
91.46
|
- | - | - | - |
Operating Expenses
|
12.26%
65.47
|
74.62 | 61.50 | 62.84 | 72.93 |
Interest Income/Expense |
6.86%
14.02
|
15.06 | 14.99 | 14.54 | 14.39 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
12.26%
65.47
|
74.62 | 61.50 | 62.84 | 72.93 |
Operating Income/Loss |
270.58%
72.27
|
-42.37 | -27.53 | -37.06 | -48.60 |
Income/Loss From Continuing Operations Before Tax |
327.09%
137.74
|
32.25 | 33.97 | -49.94 | -61.72 |
Income Tax Expense/Benefit, Deferred |
-4.412
|
- | - | - | - |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
208.30%
61.02
|
-56.34 | -41.25 | -49.94 | -61.72 |
Net Income/Loss
|
208.30%
61.02
|
-56.34 | -41.25 | -49.94 | -61.72 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
5,302%
169.26
|
3.133 | 111.87 | 109.24 | 78.44 |
Diluted Average Shares |
5,953%
189.64
|
3.133 | 111.87 | 109.24 | 78.44 |
Basic Earnings Per Share |
172.00%
0.36
|
-0.50 | -0.37 | -0.46 | -0.79 |
Diluted Earnings Per Share |
168.00%
0.34
|
-0.50 | -0.37 | -0.46 | -0.79 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):